Listening to patients: how does restarting cancer treatment affect their lives?
NCT ID NCT06050434
Summary
This study aimed to understand how patients with soft tissue sarcoma feel when they restart treatment with a chemotherapy drug called trabectedin. Researchers asked patients to report their symptoms, distress, and quality of life using questionnaires. The goal was to gather real-world information to help doctors better support patients during this specific treatment approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT-TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frankfurt Universitätsklinikum
Frankfurt am Main, Germany
-
HELIOS KLinikum Bad Saarow
Bad Saarow, Germany
-
HELIOS Klinikum Berlin Buch
Berlin, Germany
-
Uniklinikum Leipzig
Leipzig, Germany
-
Universitätsklinikum Tübingen
Tübingen, Germany
-
Universitätsmedizin Greifswald
Greifswald, Germany
-
Universitätsmedizin Göttingen
Göttingen, Germany
-
Universitätsmedizin Mainz
Mainz, Germany
-
Westfälische Wilhelms-Universität Münster
Münster, Germany
Conditions
Explore the condition pages connected to this study.